Re: list of reassortment studies
VN1203=V=A/Vietnam/1203/2004(H5N1)
CH58=C=A/Ck/Vietnam/C58/2004(H5N1)
CA09=M=A/California/04/2009(pH1N1)
NY312=N=A/New York/312/2001(H1N1)
S09=O=A/green winged teal/Ohio/175/1986(H2N1)
1918=8=A/Brevig Mission/1/1918(H1N1)
6=1918-K627E=68888888
E=NY-K627E=ENNNNNNN
K=S09-E627K=KOOOOOOO
CA09-E627K=XMMMMMMM
CA09-D701N=YMMMMMMM
rNY312=NY312=NNNNNNNN
rNY312-K27E=ENNNNNNN
1918RNP=888N8NNNN
1918RNP-K627E=688N8NNN
VN1203RNP=VVVNVNNN
S09RNP=OOONONNN
S09RNP-E627K=KOONONNN
CA09RNP=MMMNMNNN
CA09RNP-E627K=XMMNMNNN
CA09RNP-D701N=YMMNMNNN
=VVVCCCCC
=CCCVVVVV
TABLE 1
Characteristics of viruses evaluated in this study
Name,Genotype,Nadir weight-change (% of baseline),Lung titer (PFU/g) at 3dpi,at 5dpi, Histopathology
-----------------------------------------------------------------------------------------------------------------------------------------------
rNY312,NY312,−0.62%,2.6e3,2.7e3,fif+vrva
rNY312-K627E,NY312, PB2-K627E,−0.57%,4.1e3,3.5e3,fif+vrva
1918RNP,1918RNP:NY312,−15.9%,7.7e5,6.5e5,mmnb+abva
1918RNP-K627E,1918RNP;PB2-K627E;NY312,+0.54%,4.4e4,2.6e5,fif+mbva
VN1203RNP,VN1203RNP:NY312,−15.7%,4.2e5,2.6e3,mmnb+ abva
S09RNP,S09RNP:NY312,−4.93%,5.2e4,1.4e2,fa+pava
S09RNP-E627K,S09RNP;PB2-E627K:NY312,−8.06%,9.9e5,2.3e5,mb+obva
CA09RNP,CA09RNP:NY312,−4.18%,2.2e5,4.1e4,mfnb+llob va
CA09RNP-E627K,CA09RNP;PB2-E627K:NY312,−0.83%,1.1e3,4.3e2,fif+vrva
CA09RNP-D701N,CA09RNP;PB2-D701N:NY312,−1.71%,1.2e4,2.5e3,fif,vrva
fif:Few inflammatory foci
vrva:very rare viral antigen
mmnb:Moderate-marked necrotizing bronchiolitis
abva:abundant bronchiolar viral antigen
mbva:minimal bronchiolar viral antigen
fa:Focal alveolitis
pava:predominantly alveolar viral antigen
mb:Mild bronchiolitis
obva:moderate bronchiolar viral antigen
mfnb:Mild, focal necrotizing bronchiolitis
llobva:low levels of bronchiolar viral antigen
------------add others to this table, add columns for MDCK,alveolar cells,ferret pathology,ferret transmission,humans
VN1203=V=A/Vietnam/1203/2004(H5N1)
CH58=C=A/Ck/Vietnam/C58/2004(H5N1)
CA09=M=A/California/04/2009(pH1N1)
NY312=N=A/New York/312/2001(H1N1)
S09=O=A/green winged teal/Ohio/175/1986(H2N1)
1918=8=A/Brevig Mission/1/1918(H1N1)
6=1918-K627E=68888888
E=NY-K627E=ENNNNNNN
K=S09-E627K=KOOOOOOO
CA09-E627K=XMMMMMMM
CA09-D701N=YMMMMMMM
rNY312=NY312=NNNNNNNN
rNY312-K27E=ENNNNNNN
1918RNP=888N8NNNN
1918RNP-K627E=688N8NNN
VN1203RNP=VVVNVNNN
S09RNP=OOONONNN
S09RNP-E627K=KOONONNN
CA09RNP=MMMNMNNN
CA09RNP-E627K=XMMNMNNN
CA09RNP-D701N=YMMNMNNN
=VVVCCCCC
=CCCVVVVV
TABLE 1
Characteristics of viruses evaluated in this study
Name,Genotype,Nadir weight-change (% of baseline),Lung titer (PFU/g) at 3dpi,at 5dpi, Histopathology
-----------------------------------------------------------------------------------------------------------------------------------------------
rNY312,NY312,−0.62%,2.6e3,2.7e3,fif+vrva
rNY312-K627E,NY312, PB2-K627E,−0.57%,4.1e3,3.5e3,fif+vrva
1918RNP,1918RNP:NY312,−15.9%,7.7e5,6.5e5,mmnb+abva
1918RNP-K627E,1918RNP;PB2-K627E;NY312,+0.54%,4.4e4,2.6e5,fif+mbva
VN1203RNP,VN1203RNP:NY312,−15.7%,4.2e5,2.6e3,mmnb+ abva
S09RNP,S09RNP:NY312,−4.93%,5.2e4,1.4e2,fa+pava
S09RNP-E627K,S09RNP;PB2-E627K:NY312,−8.06%,9.9e5,2.3e5,mb+obva
CA09RNP,CA09RNP:NY312,−4.18%,2.2e5,4.1e4,mfnb+llob va
CA09RNP-E627K,CA09RNP;PB2-E627K:NY312,−0.83%,1.1e3,4.3e2,fif+vrva
CA09RNP-D701N,CA09RNP;PB2-D701N:NY312,−1.71%,1.2e4,2.5e3,fif,vrva
fif:Few inflammatory foci
vrva:very rare viral antigen
mmnb:Moderate-marked necrotizing bronchiolitis
abva:abundant bronchiolar viral antigen
mbva:minimal bronchiolar viral antigen
fa:Focal alveolitis
pava:predominantly alveolar viral antigen
mb:Mild bronchiolitis
obva:moderate bronchiolar viral antigen
mfnb:Mild, focal necrotizing bronchiolitis
llobva:low levels of bronchiolar viral antigen
------------add others to this table, add columns for MDCK,alveolar cells,ferret pathology,ferret transmission,humans
Comment